A Regulator's View on Managing Other Risks in Banking

被引:0
|
作者
Jeremy Quick
机构
[1] Financial Services Authority (FSA),
关键词
Banking; risk management; other risks; supervision; capital adequacy;
D O I
10.1057/palgrave.rm.8240055
中图分类号
学科分类号
摘要
This paper describes the changing pattern of risk in the banking sector, along with the response of both regulators and supervisors to the problems posed by this change. A major issue is the emergence of ‘other risks’, a category of risk that is not currently adequately catered for under current international banking supervision agreements. New proposals are outlined to deal with such risks, building on the strengths of existing agreements and taking into account a number of barriers to the adoption of this new regulatory framework. We conclude that, whilst these proposals are themselves rooted in change, they will result in a significant shift in terminology and behaviours.
引用
收藏
页码:15 / 21
页数:6
相关论文
共 50 条
  • [31] Managing risks
    Shipping World and Shipbuilder, 2005, 206 (4218): : 10 - 11
  • [33] FROM MANAGING DISASTERS TO MANAGING RISKS, REDUCING EXISTING RISKS
    Olsson, Mette Lindahl
    INJURY PREVENTION, 2016, 22 : A3 - A3
  • [34] Stress Analysis in Managing the Region's Budget Risks
    Pazdnikova, N. N.
    Shipitsyna, S. Ye.
    EKONOMIKA REGIONA-ECONOMY OF REGION, 2014, 3 : 208 - 217
  • [35] Registration of biological pesticides: A regulator's view point
    Hughes, W
    PROCEEDINGS OF THE FIFTIETH NEW ZEALAND PLANT PROTECTION CONFERENCE, 1997, : 146 - 149
  • [36] New medical device regulations: the regulator's view
    Melvin, Tom
    Torre, Marina
    EFORT OPEN REVIEWS, 2019, 4 (06): : 351 - 356
  • [37] Pharmacokinetics and Generic Drug Switching: A Regulator’s View
    Pieter J. Glerum
    Cees Neef
    David M. Burger
    Yang Yu
    Marc Maliepaard
    Clinical Pharmacokinetics, 2020, 59 : 1065 - 1069
  • [38] Hazard and risk assessment for construction: a regulator's view
    Structural Engineer, 1995, 73 (22):
  • [39] Pharmacokinetics and Generic Drug Switching: A Regulator's View
    Glerum, Pieter J.
    Neef, Cees
    Burger, David M.
    Yu, Yang
    Maliepaard, Marc
    CLINICAL PHARMACOKINETICS, 2020, 59 (09) : 1065 - 1069
  • [40] The regulator's view: Non-nuclear applications
    Bainbridge, H
    Methods for the Assessment of Structural Integrity of Components and Structures, 2003, : 37 - 48